Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action

Report
Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy. This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

Author:

Stop TB Partnership

Audiences:

International Agencies, Policy Makers

Topic:

Extensively Drug-Resistant TB (XDR TB), MDR TB, TB Treatment, Treatment- TB Disease

View Webpage

Related Materials

Characteristics of Second-Line Drugs for MDR-TB

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

Fact Sheet

Timeline: Path to TB Innovation

This timeline shows TB innovations throughout history.

Fact Sheet

Prospectus: Global TB Drug Facility: A Global Mechanism to Ensure Uninterrupted Access to Quality TB Drugs for DOTS Implementation

This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).

Report

Global resources for the prevention,
management, and elimination of TB.